<font color="blue">Inverse_1</font> <font color="blue">Effect_2</font> of Fluoxetine on <font color="blue">Medial_2</font> <font color="blue">Prefrontal_2</font> <font color="blue">Cortex_2</font> <font color="blue">Activation_2</font> During Reward Reversal in <font color="blue">ADHD_1</font> <font color="blue">and_1</font> <font color="blue">Autism_1</font> <font color="blue">._1</font> 
<br>
<br> <font color="blue">Attention_1</font> <font color="blue">deficit_1</font> <font color="blue">hyperactivity_1</font> <font color="blue">disorder_1</font> <font color="blue">(_1</font> <font color="blue">ADHD_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">autism_1</font> <font color="blue">spectrum_1</font> <font color="blue">disorder_1</font> <font color="blue">(_1</font> <font color="blue">ASD_1</font> <font color="blue">)_1</font> share <font color="blue">brain_1</font> <font color="blue">function_1</font> <font color="blue">abnormalities_1</font> during cognitive flexibility . Serotonin is involved in both disorders , and <font color="blue">selective_1</font> <font color="blue">serotonin_1</font> <font color="blue">reuptake_1</font> <font color="blue">inhibitors_1</font> <font color="blue">(_1</font> <font color="blue">SSRIs_1</font> <font color="blue">)_1</font> can modulate <font color="blue">cognitive_1</font> <font color="blue">flexibility_1</font> and improve <font color="blue">behavior_1</font> in both disorders . Thus , this study <font color="blue">investigates_1</font> <font color="blue">shared_2</font> <font color="blue">and_2</font> <font color="blue">disorder_2</font> <font color="blue">-_2</font> <font color="blue">specific_2</font> <font color="blue">brain_2</font> <font color="blue">dysfunctions_2</font> <font color="blue">in_1</font> <font color="blue">these_1</font> <font color="blue">2_1</font> <font color="blue">disorders_1</font> <font color="blue">during_1</font> <font color="blue">reward_1</font> <font color="blue">reversal_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">the_1</font> <font color="blue">acute_1</font> <font color="blue">effects_1</font> <font color="blue">of_1</font> <font color="blue">an_1</font> <font color="blue">SSRI_1</font> <font color="blue">on_1</font> <font color="blue">these_1</font> <font color="blue">._1</font> Age - matched boys with <font color="blue">ADHD_1</font> ( 15 ) , ASD ( 18 ) , and controls ( 21 ) were compared with <font color="blue">functional_1</font> <font color="blue">magnetic_1</font> <font color="blue">resonance_1</font> <font color="blue">imaging_1</font> <font color="blue">(_1</font> <font color="blue">fMRI_1</font> <font color="blue">)_1</font> during a reversal task . Patients were <font color="blue">scanned_1</font> twice , under either an acute dose of Fluoxetine or placebo in a double - blind , placebo - controlled randomized design . <font color="blue">Repeated_1</font> <font color="blue">-_1</font> <font color="blue">measures_1</font> <font color="blue">analyses_1</font> <font color="blue">within_1</font> <font color="blue">patients_1</font> <font color="blue">assessed_2</font> <font color="blue">drug_4</font> <font color="blue">effects_4</font> <font color="blue">._4</font> <font color="blue">Patients_1</font> <font color="blue">under_1</font> <font color="blue">each_1</font> <font color="blue">drug_1</font> <font color="blue">condition_1</font> <font color="blue">were_1</font> <font color="blue">compared_1</font> <font color="blue">with_1</font> <font color="blue">controls_1</font> <font color="blue">to_1</font> <font color="blue">assess_1</font> <font color="blue">normalization_2</font> <font color="blue">effects_2</font> <font color="blue">._2</font> fMRI data showed that , under placebo , ASD boys <font color="blue">underactivated_1</font> <font color="blue">medial_2</font> <font color="blue">prefrontal_2</font> <font color="blue">cortex_2</font> <font color="blue">(_2</font> <font color="blue">mPFC_2</font> <font color="blue">)_2</font> <font color="blue">,_2</font> compared with control and <font color="blue">ADHD_1</font> boys . Both patient groups shared <font color="blue">decreased_1</font> <font color="blue">precuneus_1</font> <font color="blue">activation_1</font> <font color="blue">._1</font> Under Fluoxetine , <font color="blue">mPFC_2</font> <font color="blue">activation_2</font> <font color="blue">was_1</font> <font color="blue">up_1</font> <font color="blue">-_1</font> <font color="blue">regulated_1</font> <font color="blue">and_1</font> <font color="blue">normalized_1</font> <font color="blue">in_1</font> <font color="blue">ASD_1</font> boys relative to controls , but <font color="blue">down_1</font> <font color="blue">-_1</font> <font color="blue">regulated_1</font> <font color="blue">in_1</font> <font color="blue">ADHD_1</font> <font color="blue">boys_1</font> relative to placebo , which was concomitant with <font color="blue">worse_1</font> <font color="blue">task_2</font> <font color="blue">performance_2</font> <font color="blue">in_2</font> <font color="blue">ADHD_2</font> <font color="blue">._2</font> Fluoxetine therefore has <font color="blue">inverse_1</font> <font color="blue">effects_1</font> <font color="blue">on_1</font> <font color="blue">mPFC_2</font> <font color="blue">activation_2</font> <font color="blue">in_2</font> <font color="blue">ASD_2</font> <font color="blue">and_2</font> <font color="blue">ADHD_2</font> <font color="blue">during_1</font> <font color="blue">reversal_1</font> <font color="blue">learning_1</font> <font color="blue">,_1</font> <font color="blue">suggesting_1</font> <font color="blue">dissociated_1</font> <font color="blue">underlying_1</font> <font color="blue">serotonin_1</font> <font color="blue">abnormalities_1</font> <font color="blue">._1</font>